Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neurogene
AddedFeb 19, 2024
UpdatedJul 3, 2026
Neurogene

Neurogene

Public

Neurogene Inc., a New York-based pharmaceutical company, specializes in developing genetic medicines for rare neurological diseases.

HQ
New York, NY, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Neurogene Inc., founded in New York, is a pharmaceutical company dedicated to developing genetic medicines for rare and devastating neurological diseases. Their core mission is to innovate and execute robust scientific solutions to create life-changing treatments for patients and their families. Neurogene's pipeline focuses on gene therapy, aiming to address the high unmet needs in the realm of neurological disorders.

Notable figures affiliated with Neurogene include experienced scientists and industry leaders in genetic medicine. The company has attracted significant investment from leading biotech venture capital firms, underscoring confidence in its potential. Neurogene's key achievements include advancing a promising gene therapy pipeline and making strides toward clinical trials. The overall impact of Neurogene lies in its potential to revolutionize treatment for rare neurological diseases, offering hope to affected individuals and their families.

Neurogene - Similar Companies

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

Empyrean Neuroscience logo

Empyrean Neuroscience

empyrean.bio

Neuraly logo

Neuraly

neuralymed.com

Neurovia logo

Neurovia

Neuron23 logo

Neuron23

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

NeuroPro Therapeutics logo

NeuroPro Therapeutics

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

Neurona Therapeutics logo

Neurona Therapeutics

Intellect Neurosciences logo

Intellect Neurosciences

Harmony Biosciences logo

Harmony Biosciences

Neurolixis logo

Neurolixis

neurolixis.com

Ovid Therapeutics logo

Ovid Therapeutics

ovidrx.com

Nido Biosciences logo

Nido Biosciences

nidobio.com

ReNeuroGen logo

ReNeuroGen

rngen.com

Neurogene - Quick Facts

Who are Neurogene's competitors?

Companies similar to Neurogene include NeuroGenetic Pharmaceuticals, Empyrean Neuroscience, Neuraly and Neurovia.

When was Neurogene founded?

Neurogene was founded in 2018.

Where is Neurogene's headquarters located?

Neurogene's headquarters is located in New York, NY, US.

When was Neurogene's last funding round?

Neurogene's most recent funding round was for $115M (USD) in December 2020.

How much has Neurogene raised to-date?

As of Dec 16, 2020, Neurogene has raised a total of $183.5M (USD).

How many employees does Neurogene have?

Neurogene has 92 employees as of Feb 5, 2024.

Neurogene - Classification

Ownership
  • Public
Technology
  • Biotech
  • Gene Therapy
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Genetic Medicines
Tags
  • Healthcare
  • Pharmaceutical
Unique IDs
  • ein: 980542593
  • secCik: 0001404644
  • ticker: NGNE
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research